ADMAX

ADMAX (Adamax) Peptide Full Introduction & Administration Guide

1. General Overview

ADMAX (Adamax) is a synthetic modified peptide derivative of Semax (ACTH 4–10 fragment). It is structurally optimized with terminal acetylation, amidation and adamantane modification. These chemical upgrades greatly improve protease resistance, metabolic stability and blood-brain barrier (BBB) permeability compared to standard Semax. It belongs to the nootropic neuropeptide family and is widely used in neuroscience laboratory research focusing on neuroprotection and cognitive regulation.

2. Mechanism of Action

1. Upregulate BDNF and NGF expression in brain tissues (hippocampus & cerebral cortex), activate TrkB signaling pathways to boost neuroplasticity.
2. Modulate central monoamine neurotransmitters (dopamine, serotonin), support emotional stability and stress resilience.
3. Protect neurons against oxidative stress, ischemia and neurotoxic damage.
4. Improve memory consolidation, information processing speed and sustained attention.

3. Main Research Observed Effects

• Enhance learning capacity, working memory and mental focus
• Neuroprotective effect against neuronal injury
• Relieve anxiety and improve mood without sedation
• Accelerate neural function recovery after brain damage
• Support cognitive performance under long-duration mental workload

4. Reconstitution Instruction (Lyophilized Powder Vial)

Most common specification: 10mg per vial

1. Slowly inject Bacteriostatic Water (BAC water) along the inner wall of the vial. Recommended solvent: 3.0 mL BAC water for 10mg vial → Concentration = 3.33 mg/mL.
2. Rotate the vial gently until powder dissolves completely. Do NOT shake violently to avoid peptide denaturation and foaming.
3. Storage rules: Unreconstituted lyophilized powder: Store at -20°C, avoid light. Reconstituted solution: Refrigerate at 2°C ~ 8°C, stable within 28 days. Avoid repeated freeze-thaw cycles.

5. Administration Protocol (Subcutaneous Injection, Research Reference)

Daily Dose & Gradual Titration Plan

• Weeks 1–2: 300 mcg (0.3 mg) per day (adaptation phase)
• Weeks 3–4: 500 mcg (0.5 mg) per day
• Weeks 5–6: 750 mcg (0.75 mg) per day
• Weeks 7+: Up to 1000 mcg (1.0 mg) per day (maintenance dose)

Timing & Injection Tips

• Frequency: Once daily, preferably in the morning.
• Injection sites: Lower abdomen or anterior thigh. Rotate injection positions regularly.
• Operation: Pinch skin fold, insert needle at 45°–90°, inject slowly over 3–5 seconds.

Cycle Schedule

• On-cycle: 8–12 weeks (maximum 16 weeks under monitoring)
• Off-cycle: Equal duration break after on-cycle (e.g., 8 weeks on → 8 weeks off)

6. Precautions

1. This product is laboratory research material only. Not approved for human medical use.
2. Do not exceed recommended dosage in experimental protocols.
3. Discontinue use immediately if abnormal local irritation or systemic discomfort appears during research observation.
4. Strictly follow sterile operation standards during reconstitution and injection.

Short Version (Can be directly used for product page / customer message)

ADMAX Peptide

ADMAX is an advanced Semax analog neuropeptide for research purposes. Modified chemical structure delivers better stability and BBB penetration. It targets BDNF signaling to study neuroplasticity, cognitive enhancement, neuroprotection and stress resistance.

Reconstitution

Mix 10mg lyophilized powder with 3mL bacteriostatic water. Gently swirl to dissolve.

Recommended Subcutaneous Research Dosage

Start at 300 mcg daily, gradually increase to 500–1000 mcg daily. Inject once per day in the morning. Cycle: 8–12 weeks on, then equal break time.